Effects of betamethasone on inflammation and emphysema induced by cadmium nebulisation in rats

Eur J Pharmacol. 2009 Mar 15;606(1-3):210-4. doi: 10.1016/j.ejphar.2009.01.020. Epub 2009 Jan 25.

Abstract

Cadmium (Cd) induces centrilobular emphysema and is suspected to contribute to tobacco related lung diseases as chronic obstructive pulmonary disease (COPD). This study aimed to check whether the inflammatory process observed in rats exposed to nebulised Cd is resistant to betamethasone as observed in COPD and to determine the influence of this drug on airspace enlargement together with the MMP-2-9/TIMP-1-2 imbalance. Our results showed that betamethasone induced emphysema by itself in healthy rats. Moreover, pre-treatment of rats with betamethasone could only partially modulate the increase in bronchoalveolar lavage fluid cell counts and the absence of preventive effect of this compound against emphysema development is associated with its inability to rebalance the MMP-2-9/TIMP-1-2 ratio.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / pharmacology
  • Betamethasone / adverse effects
  • Betamethasone / pharmacology*
  • Bronchoalveolar Lavage Fluid
  • Cadmium / administration & dosage*
  • Cadmium / toxicity*
  • Cell Count
  • Male
  • Matrix Metalloproteinases / metabolism
  • Microscopy
  • Nebulizers and Vaporizers
  • Pneumonia / chemically induced*
  • Pneumonia / metabolism
  • Pneumonia / pathology
  • Pulmonary Emphysema / chemically induced*
  • Pulmonary Emphysema / metabolism
  • Pulmonary Emphysema / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Inhibitor of Metalloproteinases / metabolism

Substances

  • Anti-Inflammatory Agents
  • Tissue Inhibitor of Metalloproteinases
  • Cadmium
  • Betamethasone
  • Matrix Metalloproteinases